Marshall Wace’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-41,046
| Closed | -$165K | – | 2846 |
|
|
2022
Q3 | $165K | Sell |
41,046
-22,378
| -35% | -$90K | ﹤0.01% | 2372 |
|
|
2022
Q2 | $355K | Sell |
63,424
-4,363
| -6% | -$24.4K | ﹤0.01% | 2278 |
|
|
2022
Q1 | $759K | Sell |
67,787
-21,411
| -24% | -$240K | ﹤0.01% | 1946 |
|
|
2021
Q4 | $1.3M | Buy |
89,198
+76,786
| +619% | +$1.12M | ﹤0.01% | 1810 |
|
|
2021
Q3 | $373K | Buy |
12,412
+8,418
| +211% | +$253K | ﹤0.01% | 1986 |
|
|
2021
Q2 | $186K | Buy |
+3,994
| New | +$186K | ﹤0.01% | 1952 |
|
|
2020
Q2 | – | Sell |
-1,039
| Closed | -$60K | – | 1925 |
|
|
2020
Q1 | $60K | Sell |
1,039
-6,169
| -86% | -$356K | ﹤0.01% | 1388 |
|
|
2019
Q4 | $520K | Buy |
7,208
+3,426
| +91% | +$247K | ﹤0.01% | 1106 |
|
|
2019
Q3 | $231K | Buy |
+3,782
| New | +$231K | ﹤0.01% | 1215 |
|